25-Nov-2024
Children’s Hospital of Philadelphia researchers identify gene signature for high-risk form of T-cell acute lymphoblastic leukemia
Children's Hospital of PhiladelphiaPeer-Reviewed Publication
Researchers have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who have a higher risk version of the disease and are more likely to relapse despite treatment. The findings allowed researchers to identify new potential therapeutic treatments for patients with this specific form of cancer with a high risk of recurrence
- Journal
- Nature Cancer
- Funder
- Alex's Lemonade Stand Foundation for Childhood Cancer, Gabriella Miller Kids First, Leukemia and Lymphoma Society, Hyundai Hope On Wheels, NIH/National Institutes of Health, St. Baldrick’s Foundation, Pennsylvania Department of Health, Harrison Willing Memorial Research Fund, Invisible Prince Foundation, Aiden Everett Davies Innovation Fund, NIH Medical Scientist Training Program, Novartis